What is an appropriate Sustained Low‑Efficiency Dialysis (SLED) prescription for a patient with a hemorrhagic cerebrovascular accident (stroke)?

SLED Prescription for Hemorrhagic CVA

For a patient with hemorrhagic CVA requiring renal replacement therapy, prescribe SLED with strict avoidance of anticoagulation, using saline flushes only, with an 8-hour treatment duration at blood flow 100-200 mL/min and dialysate flow 300-350 mL/min, while maintaining tight blood pressure control to prevent intracranial pressure elevation.

Critical Anticoagulation Considerations

The most important aspect of SLED in hemorrhagic stroke is complete avoidance of systemic anticoagulation 1. While KDOQI guidelines recommend anticoagulation for patients receiving RRT who are not at increased bleeding risk 2, hemorrhagic CVA represents an absolute contraindication to heparin use.

Anticoagulation-Free Protocol

• Use saline flushes only - no heparin, no citrate anticoagulation 3
• Accept higher filter clotting rates (approximately 29% of heparin-free treatments) as this is safer than risking hemorrhage expansion 3
• Regional citrate anticoagulation, while effective, should be avoided given the bleeding risk and complexity of monitoring in this population 4

SLED Technical Parameters

Treatment Duration and Frequency

• 8-hour sessions, 6 days per week is the standard prescription 3, 5
• Shorter 4-hour SLED sessions may be appropriate if hemodynamically stable and can achieve adequate solute clearance 6
• This provides equivalent renal clearance (EKR ~29 mL/min) to CRRT while reducing nursing time and costs 3

Blood and Dialysate Flow Rates

• Blood flow: 100-200 mL/min 7, 3, 5
• Dialysate flow: 300-350 mL/min 3
• These lower flows compared to conventional hemodialysis provide hemodynamic stability critical for brain hemorrhage patients

Ultrafiltration Management

• Set ultrafiltration rate at 1.0-1.5 kg per 8-hour session based on fluid status 7
• Minimize net ultrafiltration to reduce hemodynamic instability 2
• Avoid aggressive fluid removal that could compromise cerebral perfusion

Hemodynamic and Intracranial Pressure Monitoring

Critical Pitfall: ICP Elevation

Both SLED and CVVH increase intracranial pressure during dialysis in brain hemorrhage patients 7. This is unavoidable but must be anticipated and managed:

• Monitor ICP continuously if available
• SLED and CVVH show identical acute hemodynamic effects in hemorrhagic stroke 7
• Stroke volume variation is slightly higher with SLED versus CVVH but both are tolerable 7

Blood Pressure Management

This is the most critical aspect for hemorrhagic CVA patients:

• Avoid hypotension - maintain adequate cerebral perfusion pressure 8, 9
• Avoid hypertension - elevated BP worsens cerebral edema and increases rebleeding risk 8
• Target systolic BP 130-180 mmHg (adjust based on specific hemorrhage characteristics and neurosurgical input) 10
• Use dialysate temperature lowering and avoid low potassium/calcium/magnesium dialysate to minimize hypotensive episodes 11

Dialysate Composition

• Bicarbonate-based dialysate (standard in contemporary practice) 2
• Calcium 1.5 mmol/L 4
• Avoid hypo-osmolar solutions that worsen cerebral edema 8
• Monitor and supplement electrolytes aggressively - approximately 25% of sessions require phosphate/magnesium supplementation 4

Monitoring Requirements

During Each SLED Session

• Continuous hemodynamic monitoring
• ICP monitoring if available
• Circuit pressures to detect clotting early
• Hourly vital signs

Laboratory Monitoring

• Pre- and post-SLED: BUN, creatinine, sodium, potassium, phosphorus, bicarbonate 6
• Daily: calcium, magnesium, complete blood count
• Coagulation parameters if any concern for DIC or other coagulopathy

Practical Implementation

Dialysis Dose

• Target weekly Kt/V of 8.4 ± 1.8 with SLED 3
• This exceeds KDOQI minimum recommendations and provides adequate solute clearance
• 4-hour SLED can achieve adequate clearance if 8-hour sessions are not feasible 6

Equipment

• Can use conventional hemodialysis machines (Fresenius, Nipro, etc.) 4, 12
• Single-pass batch dialysis systems are effective 5
• High-flux cellulose triacetate filters preferred 4

Common Pitfalls to Avoid

1. Never use systemic anticoagulation - hemorrhage expansion risk outweighs filter clotting
2. Do not aggressively ultrafiltrate - cerebral perfusion compromise worsens outcomes
3. Avoid rapid electrolyte shifts - can precipitate seizures or worsen cerebral edema 8
4. Do not use hypo-osmolar dialysate - worsens brain edema 8
5. Monitor for hyperperfusion if patient had prior cerebral ischemia - rare but devastating 13

Expected Outcomes

With appropriate SLED prescription:

• AKI recovery rate approximately 25% 6
• In-hospital mortality driven primarily by neurological injury, not dialysis complications 14
• Hemodynamic stability comparable to CRRT 7, 5
• Reduced nursing time and costs versus CRRT 3, 5